✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Roche Holding AG

Common Name
Roche Holding
Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
103,249
Ticker
ROG
Exchange
SIX SWISS EXCHANGE
Description
Roche Holding AG is a prominent healthcare company specializing in pharmaceuticals and diagnostics. Headquartered in Basel, Switzerland, Roche operates globally with a strong focus on providing medica...

Roche Holding's GHG Emissions Data Preview

In 2024, Roche Holding completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Roche Holding has also provided a category-level breakdown for 11 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Total Scope 2
Market-Based
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Location-Based
Copy/Paste is a PRO feature.
0000000
Copy/Paste is a PRO feature.
0000000
Unspecified Calculation Method
Copy/Paste is a PRO feature.
0000000
Copy/Paste is a PRO feature.
0000000
Total Scope 3
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Limited Data Preview
You are viewing a limited preview of Roche Holding’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2019, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=ROG&reporting_period=2024"

Verified Sources Behind Roche Holding’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Roche Holding’s data sources below and access millions more through our Disclosure Search.

a. Roche Holding's Annual Report 2024
b. Roche Holding's Annual Report 2020

Insights into Roche Holding's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Roche Holding amounted to 315,030 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Roche Holding decreased by 7%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Roche Holding's Scope 1 Emissions Over Time

201920202021202220232024075 k150 k225 k300 ktCO2e-11%-1%-2%-4%+2%
  • Total Scope 1
  • Year-over-Year Change

What are Roche Holding's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Roche Holding were 245,832 metric tons of CO₂ equivalent (tCO₂e).a

Has Roche Holding reduced its Scope 1 emissions over time?

Since 2019, Roche Holding's Scope 1 emissions have decreased by 14.69%, reflecting a declining long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2023), Roche Holding's Scope 1 emissions increased by 2.32%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Roche Holding's Scope 2 emissions?

In 2024, Roche Holding reported Scope 2 greenhouse gas (GHG) emissions of 69,198 tCO₂e using the market-based method.a

Has Roche Holding reduced its Scope 2 emissions over time?

Since 2019, Roche Holding's Scope 2 greenhouse gas (GHG) emissions (Market-Based) have decreased by 64.65%, reflecting a declining long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2023), Roche Holding's Scope 2 emissions (Market-Based) fell by 29.73% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a

What methodology does Roche Holding use for Scope 2 reporting?

In 2024, Roche Holding reported its Scope 2 emissions using the market-based method.a

Roche Holding's Scope 2 Emissions Over Time

201920202021202220232024050 k100 k150 k200 ktCO2e
  • Total Scope 2 Market-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Roche Holding's Value Chain Emissions

In 2024, Roche Holding reported 5,478,525 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of Roche Holding includes a breakdown across 11 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Roche Holding's Scope 3 Emissions Over Time

20192020202120222023202402 M4 M6 M8 MtCO2e-72%+13772%-19%-7%-9%
  • Total Scope 3
  • Year-over-Year Change

What are Roche Holding's Scope 3 emissions?

In 2024, Roche Holding reported total Scope 3 emissions of 5,478,525 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 91.43% of these emissions originated from upstream activities such as purchased goods and capital goods, while 8.57% came from downstream activities like product use, distribution, and end-of-life treatment.a

Has Roche Holding reduced its Scope 3 emissions over time?

Since 2019, Roche Holding's Scope 3 emissions have increased by 2,618.57%, reflecting a rising long-term trend in Scope 3 emissions over time.ab

Compared to the previous year (2023), Roche Holding's Scope 3 emissions remained relatively stable, indicating that Roche Holding's emissions have plateaued with no significant change in its value chain footprint.a

What categories of Scope 3 emissions does Roche Holding disclose?

In 2024, Roche Holding reported emissions for 11 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Roche Holding's Scope 3 emissions?

In 2024, the largest contributors to Roche Holding's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 3,886,248 tCO₂e (70.94%)
  • Capital Goods (Cat. 2): 534,508 tCO₂e (9.76%)
  • Upstream Transportation and Distribution (Cat. 4): 252,795 tCO₂e (4.61%)

Roche Holding's Scope 3 Emissions by Categories

Capital Goods(Cat. 2)(9.8%)UpstreamTransportation andDistribution(Cat. 4)(4.6%)Purchased Goods andServices (Cat. 1)(70.9%)

Insights into Roche Holding’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Roche Holding reported Scope 1 greenhouse gas (GHG) emissions of 245,832 tCO₂e and total revenues of USD 68,903 millions. This translates into an emissions intensity of 3.57 tCO₂e per millions USD.a

Roche Holding's Scope 1 Emissions Intensity Compared to Peers

1002,00050,000500,00010,000,000Scope 1 Emissions (tCO2e)1005005,00020,000200,000Revenues (Millions of USD)SZTONovartisYear: 2024Scope 1: 207,000 tCO2eRevenue: $M 41,706Scope 1 Intensity: 4.96 tCO2e/$MEli Lilly and CoYear: 2024Scope 1: 192,000 tCO2eRevenue: $M 45,043Scope 1 Intensity: 4.26 tCO2e/$MBristol-Myers SquibbYear: 2024Scope 1: 206,726 tCO2eRevenue: $M 48,300Scope 1 Intensity: 4.28 tCO2e/$MNovo NordiskYear: 2024Scope 1: 85,000 tCO2eRevenue: $M 40,472Scope 1 Intensity: 2.10 tCO2e/$MJCR PharmaceuticalsYear: 2022Scope 1: 3,315 tCO2eRevenue: $M 419Scope 1 Intensity: 7.92 tCO2e/$MSSSanofi IndiaYear: 2024Scope 1: 510 tCO2eRevenue: $M 232Scope 1 Intensity: 2.20 tCO2e/$MGilead SciencesYear: 2024Scope 1: 53,856 tCO2eRevenue: $M 28,754Scope 1 Intensity: 1.87 tCO2e/$MCosmo PharmaceuticalsYear: 2024Scope 1: 5,658 tCO2eRevenue: $M 260Scope 1 Intensity: 21.74 tCO2e/$MSanten PharmaceuticalYear: 2024Scope 1: 17,372 tCO2eRevenue: $M 1,994Scope 1 Intensity: 8.71 tCO2e/$MBiogenYear: 2024Scope 1: 56,611 tCO2eRevenue: $M 9,676Scope 1 Intensity: 5.85 tCO2e/$MMerck KGaAYear: 2024Scope 1: 858,053 tCO2eRevenue: $M 22,015Scope 1 Intensity: 38.98 tCO2e/$MOno PharmaceuticalYear: 2024Scope 1: 8,100 tCO2eRevenue: $M 3,319Scope 1 Intensity: 2.44 tCO2e/$MKalbe FarmaYear: 2024Scope 1: 19,895 tCO2eRevenue: $M 2,028Scope 1 Intensity: 9.81 tCO2e/$MZZZhangzhou Pientzehuang PharmaceuticalYear: 2023Scope 1: 2,301 tCO2eRevenue: $M 1,415Scope 1 Intensity: 1.63 tCO2e/$MPfizerYear: 2024Scope 1: 613,218 tCO2eRevenue: $M 63,627Scope 1 Intensity: 9.64 tCO2e/$MChugai PharmaceuticalYear: 2024Scope 1: 51,143 tCO2eRevenue: $M 7,456Scope 1 Intensity: 6.86 tCO2e/$MOtsuka HoldingsYear: 2024Scope 1: 368,733 tCO2eRevenue: $M 14,840Scope 1 Intensity: 24.85 tCO2e/$MAmgenYear: 2024Scope 1: 147,000 tCO2eRevenue: $M 33,424Scope 1 Intensity: 4.40 tCO2e/$MVirbacYear: 2024Scope 1: 10,966 tCO2eRevenue: $M 1,454Scope 1 Intensity: 7.54 tCO2e/$MMerck & Co IncYear: 2024Scope 1: 721,200 tCO2eRevenue: $M 64,168Scope 1 Intensity: 11.24 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MTTTong Ren Tang TechnologiesYear: 2024Scope 1: 30,000 tCO2eRevenue: $M 1,086Scope 1 Intensity: 27.62 tCO2e/$MKyowa KirinYear: 2024Scope 1: 16,133 tCO2eRevenue: $M 3,157Scope 1 Intensity: 5.11 tCO2e/$MOOOrion OyjYear: 2024Scope 1: 5,625 tCO2eRevenue: $M 1,605Scope 1 Intensity: 3.50 tCO2e/$MRoche HoldingYear: 2024Scope 1: 245,832 tCO2eRevenue: $M 68,903Scope 1 Intensity: 3.57 tCO2e/$M

How does Roche Holding's GHG emissions intensity compare to its peers?

In 2024, Roche Holding reported a Scope 1 emissions intensity of 3.57 tCO₂e per millions USD. Compared to the peer group median of 6.35, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Roche Holding rank on GHG emissions intensity within its industry?

In 2024, Roche Holding ranked 7 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Roche Holding is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Insights into Roche Holding's Total Carbon Footprint

In 2024, Roche Holding reported a total carbon footprint of 5,793,555 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 8.47% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.a

The largest contributor to Roche Holding's total carbon footprint was Scope 3 emissions, accounting for 94.56% of the company's total carbon footprint, followed by Scope 1 emissions at 4.24%.a

Want Full Access to Roche Holding's GHG Emissions Dataset?
Start 30-Day Free Trial